The investigation of the effects of topiramate on the hypothalamic levels of fat mass/obesity-associated protein and neuropeptide Y in obese female rats

References

• Hatemi H, Yumuk VD, Turan N, Arık N. Prevalence of overweight and obesity in Turkey. Metab Syndr Relat Disord 2003;1:285–90. doi: 10.1089/1540419031361363
   PubMed Web of Science ®Google Scholar
• Taner D. Fonksiyonel nöroanatami. Ankara: METU Press; 2005, pp. 186–93.
   Google Scholar
• Yıldırım EA, Turhan S. Anksiyete, stress ve yeme davranışında nöropeptid Y. Düşünen Adam 2002;15:173–81.
   Google Scholar
• Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007;316:889–94. doi: 10.1126/science.1141634
   PubMed Web of Science ®Google Scholar
• Olszewski PK, Fredriksson R, Olszewska AM, Stephansson O, Alsio J, Radomska KJ, et al. Hypothalamic FTO is associated with the regulation of energy intake not feeding reward. BMC Neurosci 2009;10:129. doi: 10.1186/1471-2202-10-129
   PubMed Web of Science ®Google Scholar
• Rankinen T, Zuberi A, Chagnon YC, Weisnagel SJ, Argyropoulos G, Walts B, et al. The human obesity gene map: the 2005 update. Obesity (Silver Spring) 2006;14(4):529–644. doi: 10.1038/oby.2006.71
   PubMed Web of Science ®Google Scholar
• Scuteri A, Sanna S, Chen W-M, Uda M, Albai G, Strait J, et al. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLos Genet 2007;3:e115. doi: 10.1371/journal.pgen.0030115
   PubMed Web of Science ®Google Scholar
• Jia G, Fu Y, Zhao X, Dai Q, Zheng G, Yang Y, et al. N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO”. Nat Chem Biol 2011;7(12):885–7. doi: 10.1038/nchembio.687
   PubMed Web of Science ®Google Scholar
• Katherine A. Fawcett, Inês Barroso. The genetics of obesity: FTO leads the way. Trends Genet 2010;26(6):266–74. doi: 10.1016/j.tig.2010.02.006
   PubMed Web of Science ®Google Scholar
• Tung YC, Yeo GS, O’Rahilly S, Coll AP. Obesity and FTO: changing focus at a complex locus. Cell Metab 2014;20:710–8. doi: 10.1016/j.cmet.2014.09.010
   PubMed Web of Science ®Google Scholar
• Li S, Loos RJF. Sık görülen obezitenin genetiğindeki ilerlemeler: örneklem büyüklüğü sorunları. Curr Opinion Lipidol 2008;19:113–21. doi: 10.1097/MOL.0b013e3282f6a7f3
   PubMedGoogle Scholar
• Paterson CA. Effects of drugs on the lens. Int Ophthalmol Clin 1971;11:63–97. doi: 10.1097/00004397-197101120-00006
   PubMedGoogle Scholar
• Kramer MS, Lane D.A. Aminorex, dexfenfluramine, and primary pulmonary hypertension. J Clin Epidemiol 1998;51:361–4. doi: 10.1016/S0895-4356(97)00289-8
   PubMed Web of Science ®Google Scholar
• Gardner DF, Kaplan MM, Stanley CA, Utiger RD. Effect of tri-iodothyronine replacement on the metabolic and pituitary responses to starvation. N Engl J Med 1979;300:579–84. doi: 10.1056/NEJM197903153001102
   PubMed Web of Science ®Google Scholar
• Kursel O. The evaluation of the levels of serum leptin, adiponectin, ghrelin, neuropeptide Y, IGF-1 and IGFBP-3 in pre-puberty epileptic children who use topiramate. Tıpta uzmanlık tezi. Mersin. 2010.
   Google Scholar
• Richard D, Ferland J, Lalonde J, Samson P, Deshaies Y. Influence of topiramate in the regulation of energy balance. Nutrition 2000;16:961–6. doi: 10.1016/S0899-9007(00)00452-4
   PubMed Web of Science ®Google Scholar
• Chengappa KNR, Levine J, Rathore D, Parepally H, Atzert R. Long-term effects of topiramate on bipolar mood instability, weight change and glycemic control: a case-series. Eur Psychiatry 2001;16:186–90. doi: 10.1016/S0924-9338(01)00562-4
   PubMed Web of Science ®Google Scholar
• Altunkaynak Z. Effects of high fat diet induced obesity on female rat livers (a histochemical study). Eur J Gen Med 2005;2(3):100–9. doi: 10.29333/ejgm/82319
   Google Scholar
• Altunkaynak BZ, Onger MÖ, Altunkaynak ME , Ayrancı E, Canan S. A brief introduction to stereology and sampling strategies: basic concepts of stereology. NeuroQuantology 2012;10(1):31–43.
   Web of Science ®Google Scholar
• Kaplan S, Canan S. Unbiased stereological techniques. NeuroQuantology 2012;10(1):9–10.
   Web of Science ®Google Scholar
• Bas O, Acer N, Mas N, Karabekir HS, Kusbeci OY, Sahin B. Stereological evaluation of the volume and volume fraction of intracranial structures in magnetic resonance images of patients with Alzheimer’s disease. Ann Anat. 2009;191:186–95. doi: 10.1016/j.aanat.2008.12.003
   PubMed Web of Science ®Google Scholar
• Unalan D, Senol V, Bayat M, Mazicioglu MM, Öztürk A, Kurtoglu S, et al. Change in waist circumference over 3 years in Turkish children and adolescents. Ann Hum Biol 2013;40:419–25. doi: 10.3109/03014460.2013.791720
   PubMed Web of Science ®Google Scholar
• Lutz TA, Woods SC. Overview of animal models of obesity. Curr Protoc Pharmacol 2012;5:61. doi:10.1002/0471141755.ph0561s58
   PubMedGoogle Scholar
• Marcondes FK, Bianchi FJ, Tanno AP. Determination of the estrous cycle phases of rats: some helpful considerations. Braz J Biol 2002;62(4A):609–14. doi: 10.1590/S1519-69842002000400008
   PubMedGoogle Scholar
• Ergün A. Obezite, besin alınımı ve vücut ağırlığının kontrolünde leptin. T Kiln Tıp Bilimleri 1998;18:220–5.
   Google Scholar
• Hetherington AW. The relation of various hypothalamic lesions to adiposity and other phenomena in the rat. Am J Physiol 1941;133:326.
   Google Scholar
• Hetherington AW, Ranson SW. The relation of various hypothalamic lesions to adiposity in the rat. J Comp Neurol 1942;76:475–99. doi: 10.1002/cne.900760308
   Google Scholar
• Brobeck JR. Mechanism of the development of obesity in animals with hypothalamic lesions. Physiol Rev 1946;26:541–59. doi: 10.1152/physrev.1946.26.4.541
   PubMed Web of Science ®Google Scholar
• Horvath TL, Nina S, Stachenfeld SD. A temperature hypothesis of hypothalamus-driven obesity. Yale J Biol Med 2014;87:149–58.
   PubMedGoogle Scholar
• Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997;88:131–41. doi: 10.1016/S0092-8674(00)81865-6
   PubMed Web of Science ®Google Scholar
• Kurrasch DM, Cheung CC, Lee FY, Tran PV, Hata K, Ingraham HA. The neonatal ventromedial hypothalamus transcriptome reveals novel markers with spatially distinct patterning. J Neurosci 2007;27:13624–34. doi: 10.1523/JNEUROSCI.2858-07.2007
   PubMed Web of Science ®Google Scholar
• Gold RM. Hypothalamic obesity: the myth of the ventromedial nucleus. Science 1973;182:488–90. doi: 10.1126/science.182.4111.488
   PubMed Web of Science ®Google Scholar
• Mieda M, Williams SC, Richardson JA, Tanaka K, Yanagisawa M. The dorsomedial hypothalamic nucleus as a putative food-entrainable circadian pacemaker. Proc Natl Acad Sci USA 2006;103:12150–5. doi: 10.1073/pnas.0604189103
   PubMed Web of Science ®Google Scholar
• Bellinger LL, Bernardis LL. The dorsomedial hypothalamic nucleus and its role in ingestive behavior and body weight regulation: lessons learned from lesioning studies. Physiol Behav 2002;76:431–42. doi: 10.1016/S0031-9384(02)00756-4
   PubMed Web of Science ®Google Scholar
• Van Passel L, Arif H, Hirsch L. Topiramate for the treatment of epilepsy and other nervous system disorders. Expert Rev Neurother 2006;6:19–31. doi: 10.1586/14737175.6.1.19
   PubMedGoogle Scholar
• Cassidy F, Ahearn E, Carroll BJ. Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients. Am J Psychiatry 1999;156:1417–20.
   PubMed Web of Science ®Google Scholar
• Barnes D, Yaffe K. The projected effect of risk factor reduction on Alzheimer’s disease prevalence. Lancet Neurol 2011;10:819–28. doi: 10.1016/S1474-4422(11)70072-2
   PubMed Web of Science ®Google Scholar
• Bray G, Hollander P, Klein S, Kushner R, Levy B, Fitchet M, et al. A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity. Obes Res 2003;11:722–33. doi: 10.1038/oby.2003.102
   PubMedGoogle Scholar
• Mc Elroy S, Hudson J, Capece J, Beyers K, Fisher A, Rosenthal N. Topiramate for the treatment of binge eating disorder associated with obesity: A placebo-controlled study. Biol Psychiatry 2007;61:1039–48. doi: 10.1016/j.biopsych.2006.08.008
   PubMed Web of Science ®Google Scholar
• Astrup A, Caterson I, Zelissen P, Guy-Grand B, Carruba M, Levy B, et al. Topiramate: long-term maintenance of weight loss induced by a low-calorie diet in obese subjects. Obes Res 2004;12:1658–69. doi: 10.1038/oby.2004.206
   PubMedGoogle Scholar
• Ben-Menachem E, Axelsen M, Johanson EH, Stagge A, Smith U. Predictors of weight loss in adults with topiramate treated epilepsy. Obes Res 2003;11:556–62. doi: 10.1038/oby.2003.78
   PubMedGoogle Scholar
• Tremblay A, Chaput JP, Bérubé-Parent S, Prud’homme D, Leblanc C, Alméras N, et al. The effect of topiramate on energy balance in obese men: a 6-month double-blind randomized placebo controlled study with a 6-month open-label extension. Eur J Clin Pharmacol 2007;63:123–34. doi: 10.1007/s00228-006-0220-1
   PubMed Web of Science ®Google Scholar
• Gensel JC, Tovar AC, Bresnahan JC, Beattie, MS. Topiramate treatment is neuroprotective and reduces oligodendrocyte loss after cervical spinal cord injury. PLoS One 2012;7:e33519. doi: 10.1371/journal.pone.0033519
   PubMed Web of Science ®Google Scholar
• Cone RD, Cowley MA, Butler AA, Fan W, Marks DL, Low MJ. The arcuate nucleus as a conduit for diverse signals relevant to energy homeostasis. Int J Obes Relat Metab Disord 2001;25(5):S63–7. doi: 10.1038/sj.ijo.0801913
   PubMed Web of Science ®Google Scholar
• Klok MD, Jakobsdottir S, Drent ML. The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review. Obes Rev 2007;8(1):21–34. doi: 10.1111/j.1467-789X.2006.00270.x
   PubMed Web of Science ®Google Scholar
• Olofsson LE, Pierce AA, Xu AW. Functional requirement of AgRP and NPY neurons in ovarian cycle-dependent regulation of food intake. Proc Natl Acad Sci USA 2009;106(37):15932–7. doi: 10.1073/pnas.0904747106
   PubMed Web of Science ®Google Scholar
• Hardie L, Trayhurn P, Abramovich D, Fowler P. Circulating leptin in women: a longitudinal study in the menstrual cycle and during pregnancy. Clin Endocrinol 1997;47(1):101–6. doi: 10.1046/j.1365-2265.1997.2441017.x
   PubMed Web of Science ®Google Scholar
• Geber S, Brandão AH, Sampaio M. Effects of estradiol and FSH on leptin levels in women with suppressed pituitary. Reprod Biol Endocrinol 2012;10:45. doi: 10.1186/1477-7827-10-45
   PubMed Web of Science ®Google Scholar
• Clegg DJ, Brown LM, Zigman JM, Kemp CJ, Strader AD, Benoit SC, et al. Estradiol-dependent decrease in the orexigenic potency of ghrelin in female rats. Diabetes 2007;56(4):1051–8. doi: 10.2337/db06-0015
   PubMed Web of Science ®Google Scholar
• Hollins-Martin CJ, van den Akker OBA, Martin CR, Preedy VR. Handbook of diet and nutrition in the menstrual cycle, periconception and fertility. Wageningen: Wageningen Academic Publishers; 2014. p. 195.
   Google Scholar
• Bertucci JI, Blanco AM, Canosa LF, Unniappan S. Estradiol and testosterone modulate the tissue-specific expression of ghrelin, ghs-r, goat and nucb2 in goldfish. Gen Comp Endocrinol 2016;228:17–23. doi: 10.1016/j.ygcen.2016.01.006
   PubMed Web of Science ®Google Scholar
• Stephens TW, Basinski M, Bristow PK, Bue-Valleskey JM, Burgett SG, Craft L, et al. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 1995;377:530–2. doi: 10.1038/377530a0
   PubMed Web of Science ®Google Scholar
• Gehlert DR. Role of hypothalamic neuropeptide Y in feeding and obesity. Neuropeptides 1999;33:329–38. doi: 10.1054/npep.1999.0057
   PubMed Web of Science ®Google Scholar
• Bannon AW, Seda J, Carmouche M, Francis JM, Norman MH, Karbon B, et al. Behavioral characterization of neuropeptide Y knockout mice. Brain Res 2000;868:79–87. doi: 10.1016/S0006-8993(00)02285-X
   PubMed Web of Science ®Google Scholar
• Woods SC, Figlewicz DP, Madden L, Porte D, Sipols AJ, Seeley RJ. NPY and food intake: discrepancies in the model. Regul Pept 1998;75–76:403–8. doi: 10.1016/S0167-0115(98)00095-0
   PubMedGoogle Scholar
• Husum H, Van Kammen D, Termeer E, Bolwig G, Mathe A. Topiramate normalizes hippocampal NPY-LI in flinders sensitive line “depressed” rats and upregulates NPY, galanin, and CRH-LI in the hypothalamus: implications for mood-stabilizing and weight loss-inducing effects. Neuropsychopharmacology 2003;28:1292–9. doi: 10.1038/sj.npp.1300178
   PubMed Web of Science ®Google Scholar
• Ozcelik AA, Serdaroglu A, Bideci A, Arhan E, Soysal Ş, Demir E, Gücüyener K. The effect of topiramate on body weight and ghrelin, leptin, and neuropeptide-Y levels of prepubertal children with epilepsy. Pediatr Neurol 2014;51:220–4. doi: 10.1016/j.pediatrneurol.2014.05.001
   PubMed Web of Science ®Google Scholar
• Ben-Haim MS, Moshitch-Moshkovitz S, Rechavi G. FTO-dependent m6A demethylation regulates adipogenesis. Cell Res 2015;25:3–4. doi: 10.1038/cr.2014.162
   PubMed Web of Science ®Google Scholar
• Church C, Moir L, Mc Murray F, Girard C, Banks GT, Teboul L, et al. Cox overexpression of FTO leads to increased food intake and results in obesity. Nature Genet 2010;42:1086–92. doi: 10.1038/ng.713
   PubMed Web of Science ®Google Scholar
• Guo F, Zhang Y, Zhang C, Wang S, Ni Y, Zhao R. Fat mass and obesity associated (FTO) gene regulates gluconeogenesis in chicken embryo fibroblast cells. Comp Biochem Physiol A MolIntegr Physiol 2015;179:149–56. doi: 10.1016/j.cbpa.2014.10.003
   PubMed Web of Science ®Google Scholar
• Marseglia L, Manti S, D’Angelo G, Nicotera A, Parisi E, Rosa GD, et al. Oxidative stress in obesity: a critical component in human diseases. Int J Mol Sci 2015;16(1):378–400. doi: 10.3390/ijms16010378
   Web of Science ®Google Scholar
• Arnone D. Review of the use of topiramate for treatment of psychiatric disorders. Ann Gen Psychiatry 2005;4:1–14. doi: 10.1186/1744-859X-4-5
   PubMedGoogle Scholar
• Lee SR, Kim SP, Kim JE. Protective effect of topiramate against hippocampal neuronal damage after global ischemia in the gerbils. Neurosci Lett 2000;281:183–6. doi: 10.1016/S0304-3940(00)00847-8
   PubMed Web of Science ®Google Scholar
• Kutluhan S, Nazıroglu M, Celik O, Yılmaz M. Effects of selenium and topiramate on lipid peroxidation and antioxidant vitamin levels in blood of pentylentetrazol-induced epileptic rats. Biol Trace Elem Res 2009;129:181–9. doi: 10.1007/s12011-008-8287-4
   PubMed Web of Science ®Google Scholar
• Armagan A, Kutluhan S, Yilmaz M, Yilmaz N, Bülbül M, Vural H, et al. Topiramate and vitamin e modulate antioxidant enzyme activities, nitric oxide and lipid peroxidation levels in pentylenetetrazol-induced nephrotoxicity in rats. Bas Clin Pharm and Toxic 2008;103:166–70. doi: 10.1111/j.1742-7843.2008.00271.x
   PubMed Web of Science ®Google Scholar
• Kubera M, Budziszewska B, Jaworska-Feil L, Basta-Kaim A, Leskiewicz M, Tetich M, et al. Effect of topiramate on the kainate induced status epilepticus, lipid peroxidation and immunoreactivity of rats. Pol J Pharmacol 2004;56:553–61.
   PubMedGoogle Scholar